MARKET

BAX

BAX

Baxter Intl
NYSE

Real-time Quotes | Nasdaq Last Sale

82.16
-1.45
-1.73%
Opening 14:37 09/20 EDT
OPEN
82.79
PREV CLOSE
83.61
HIGH
83.17
LOW
82.16
VOLUME
1.13M
TURNOVER
--
52 WEEK HIGH
88.32
52 WEEK LOW
73.12
MARKET CAP
41.07B
P/E (TTM)
37.67
1D
5D
1M
3M
1Y
5Y
Medical Adhesive Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast to 2028
Research Nester has released a report titled " " which delivers detailed overview of the globalmedical adhesive market in terms of market segmentation by product type, application, and by region.
AmericaNewsHour · 11h ago
Bone Wax Market: Company Profiles, Growth Strategy, Developing Technologies, Opportunities and Forecast by Regions till 2028
Research Nester published a report titled which delivers a detailed overview of the bone wax market in terms of market segmentation by product, material, application, end-user and by region.
AmericaNewsHour · 12h ago
Here are Monday's biggest analyst calls of the day: Amazon, Apple, Nike, Exxon, GM & more
Here are the biggest calls on Wall Street on Monday.
CNBC.com · 09/13 12:25
Cowen & Co. Upgrades Baxter Intl to Outperform, Announces $98 Price Target
Cowen & Co. analyst Joshua Jennings upgrades Baxter Intl (NYSE:BAX) from Market Perform to Outperform and announces $98 price target.
Benzinga · 09/13 11:49
Cowen Upgrades Baxter International to Outperform From Market Perform, Lifts PT to $98 From $90
MT Newswires · 09/13 09:57
BRIEF-Baxter Issues Urgent Medical Device Correction To Reinforce Safety Information For Dose IQ Safety Software Desktop Application V.9.0X
reuters.com · 09/10 15:01
Miromatrix Welcomes Dr. John Barry as Vice President of Research and Development
EDEN PRAIRIE, Minn., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients' lives, today announced t...
GlobeNewswire · 09/09 12:00
Hill-Rom Downgraded by KeyBanc Following Proposed Acquisition by Baxter
MT Newswires · 09/08 15:33
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of BAX. Analyze the recent business situations of Baxter Intl through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 15 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average BAX stock price target is 94.21 with a high estimate of 105.00 and a low estimate of 82.00.
EPS
Institutional Holdings
Institutions: 1.52K
Institutional Holdings: 460.40M
% Owned: 92.10%
Shares Outstanding: 499.91M
TypeInstitutionsShares
Increased
359
19.00M
New
91
4.07M
Decreased
381
23.31M
Sold Out
65
4.64M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-2.16%
Healthcare Equipment & Supplies
-2.04%
Key Executives
Chairman/President/Chief Executive Officer/Director
Jose Almeida
Chief Financial Officer/Executive Vice President
James Saccaro
Senior Vice President/General Counsel
Sean Martin
Senior Vice President/Director of Human Resources
Jeanne Mason
Senior Vice President
Giuseppe Accogli
Senior Vice President
James Borzi
Senior Vice President
Cristiano Franzi
Senior Vice President
Andrew Frye
Senior Vice President
Jacqueline Kunzler
Lead Director/Independent Director
Albert Stroucken
Independent Director
Thomas Chen
Independent Director
John Forsyth
Independent Director
Peter Hellman
Independent Director
Michael Mahoney
Independent Director
Patricia Morrison
Independent Director
Stephen Oesterle
Independent Director
Cathy Smith
Independent Director
Thomas Stallkamp
Independent Director
Amy Wendell
Independent Director
David Wilkes
Declaration Date
Dividend Per Share
Ex-Div Date
07/12/2021
Dividend USD 0.28
09/02/2021
05/03/2021
Dividend USD 0.28
06/03/2021
02/16/2021
Dividend USD 0.245
02/25/2021
11/16/2020
Dividend USD 0.245
12/03/2020
07/14/2020
Dividend USD 0.245
08/28/2020
05/05/2020
Dividend USD 0.245
06/04/2020
02/18/2020
Dividend USD 0.22
02/27/2020
11/19/2019
Dividend USD 0.22
12/05/2019
07/16/2019
Dividend USD 0.22
08/29/2019
05/07/2019
Dividend USD 0.22
06/06/2019
02/19/2019
Dividend USD 0.19
02/28/2019
11/13/2018
Dividend USD 0.19
11/30/2018
07/17/2018
Dividend USD 0.19
08/30/2018
05/08/2018
Dividend USD 0.19
05/31/2018
02/20/2018
Dividend USD 0.16
03/01/2018
11/14/2017
Dividend USD 0.16
11/30/2017
07/18/2017
Dividend USD 0.16
08/30/2017
05/02/2017
Dividend USD 0.16
05/31/2017
02/21/2017
Dividend USD 0.13
03/01/2017
11/08/2016
Dividend USD 0.13
11/30/2016
About BAX
Baxter International Inc., through its subsidiaries, provides a portfolio of essential healthcare products. The Company’s products include renal care, medication delivery, pharmaceuticals, clinical nutrition, advanced surgery and acute therapies. Its renal care offering includes peritoneal dialysis (PD), hemodialysis (HD) and additional dialysis therapies and services. Its medication delivery offerings include intravenous (IV) therapies, infusion pumps, administration sets and drug reconstitution devices. Its pharmaceuticals offerings include premixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services. Its clinical nutrition offerings include parenteral nutrition (PN) therapies and related products. Its advanced surgery offerings include biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention. It also offers polysaccharide hemostatic system (PerClot) products.

Webull offers kinds of Baxter International Inc stock information, including NYSE:BAX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BAX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading BAX stock methods without spending real money on the virtual paper trading platform.